AP2008004503A0 - Use of cicletanine and other furo-pyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension
- Google Patents
Use of cicletanine and other furo-pyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/356,158external-prioritypatent/US20070105817A1/en
Application filed by Navitas PharmafiledCriticalNavitas Pharma
Publication of AP2008004503A0publicationCriticalpatent/AP2008004503A0/en
AP2008004503A2006-01-112006-11-07Use of cicletanine and other furo-pyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension
AP2008004503A0
(en)
Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
Use of cicletanine and other furo-pyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension
Use of cicletanine and other furo-pyridines for treatment of systolic predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension
Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure and general hypertension